8.89
price down icon6.93%   -0.70
 
loading
전일 마감가:
$9.59
열려 있는:
$9.36
하루 거래량:
2.79M
Relative Volume:
0.65
시가총액:
$3.28B
수익:
$6.41B
순이익/손실:
$1.30B
주가수익비율:
1.7639
EPS:
5.04
순현금흐름:
$646.00M
1주 성능:
-29.83%
1개월 성능:
-31.61%
6개월 성능:
-45.78%
1년 성능:
-54.49%
1일 변동 폭
Value
$8.84
$9.41
1주일 범위
Value
$8.8836
$13.24
52주 변동 폭
Value
$8.8836
$23.10

오가논 & Co Stock (OGN) Company Profile

Name
명칭
Organon Co
Name
전화
551-430-6000
Name
주소
30 HUDSON STREET, JERSEY CITY
Name
직원
10,000
Name
트위터
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
OGN's Discussions on Twitter

OGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
OGN
Organon Co
8.8977 3.28B 6.41B 1.30B 646.00M 5.04
Drug Manufacturers - General icon
LLY
Lilly Eli Co
825.70 739.75B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
154.90 370.90B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
196.46 340.25B 57.37B 4.20B 17.83B 2.35
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
69.37 277.97B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
113.47 222.45B 53.22B 12.86B 14.85B 6.39

오가논 & Co Stock (OGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-09-06 다운그레이드 JP Morgan Neutral → Underweight
2023-11-03 다운그레이드 Goldman Buy → Neutral
2023-09-21 개시 Barclays Overweight
2023-03-16 개시 Raymond James Outperform
2022-10-14 다운그레이드 BofA Securities Neutral → Underperform
2022-09-06 업그레이드 Piper Sandler Neutral → Overweight
2022-08-05 다운그레이드 BofA Securities Buy → Neutral
2022-04-27 개시 Goldman Buy
2022-04-06 재개 Morgan Stanley Equal-Weight
2021-10-07 개시 Piper Sandler Neutral
2021-09-01 개시 BofA Securities Buy
2021-07-22 개시 Citigroup Buy
2021-06-15 개시 JP Morgan Neutral
2021-06-11 개시 Morgan Stanley Equal-Weight
2021-06-10 개시 Evercore ISI Outperform
모두보기

오가논 & Co 주식(OGN)의 최신 뉴스

pulisher
06:00 AM

OGN INVESTIGATION ALERT: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm - PR Newswire

06:00 AM
pulisher
May 04, 2025

Organon's (NYSE:OGN) Dividend Is Being Reduced To $0.02 - simplywall.st

May 04, 2025
pulisher
May 03, 2025

Organon & Co. (NYSE:OGN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025
pulisher
May 02, 2025

SLQT INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into SelectQuote, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - GlobeNewswire Inc.

May 02, 2025
pulisher
May 02, 2025

OGN INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

May 02, 2025
pulisher
May 02, 2025

Organon projects over $1B in Nexplanon revenue for 2025 amid continued expansion - MSN

May 02, 2025
pulisher
May 02, 2025

Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (OGN) - Seeking Alpha

May 02, 2025
pulisher
May 02, 2025

Organon downgraded to In Line from Outperform at Evercore ISI - MSN

May 02, 2025
pulisher
May 02, 2025

Organon & Co. SEC 10-Q Report - TradingView

May 02, 2025
pulisher
May 02, 2025

Evercore ISI Downgrades Organon to In Line From Outperform - marketscreener.com

May 02, 2025
pulisher
May 01, 2025

Organon Stock Tumbles To Record Low On Downgrades And Dividend Cut: Retail Optimism Persists - MSN

May 01, 2025
pulisher
May 01, 2025

Organon & Co. Earnings Call: Growth Amid Challenges - TipRanks

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Faces Downgrade Following Dividend Reduction | OGN Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Organon Co earnings beat by $0.11, revenue fell short of estimates - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Faces Price Target Reduction and Dividend Cut | OG - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Organon & Co. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsOGN - Business Wire

May 01, 2025
pulisher
May 01, 2025

OGN Investors Have Opportunity to Join Organon & Co. Fraud Investigation with the Schall Law Firm - Business Wire

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Significantly Reduces Quarterly Dividend | OGN Sto - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Sees Growth in Nexplanon and Strategic Restructuri - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Organon slashes dividend - CNBC

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Expands Board with New Appointment - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Set to Announce Q1 2025 Financial Results - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Slashes Quarterly Dividend by 92.9% - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Earnings call transcript: Organon Q1 2025 results show mixed signals By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Earnings call transcript: Organon Q1 2025 results show mixed signals - Investing.com

May 01, 2025
pulisher
May 01, 2025

Organon & Co. 2025 Q1ResultsEarnings Call Presentation (NYSE:OGN) - Seeking Alpha

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq

May 01, 2025
pulisher
May 01, 2025

Organon Shares Fall After Lower Q1 Adjusted Earnings, Revenue - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q1 But Stock Drops 23.5% - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Organon stock hits 52-week low at $10.18 amid market challenges - Investing.com

May 01, 2025
pulisher
May 01, 2025

Organon & Co Q1 2025 Earnings: Revenue Beats at $1.513 Billion, EPS Misses at $0.33 - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Organon & Co reports results for the quarter ended March 31Earnings Summary - TradingView

May 01, 2025
pulisher
May 01, 2025

Organon Q1 2025 slides: Women’s Health growth offsets revenue headwinds By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Organon Q1 2025 slides: Women’s Health growth offsets revenue headwinds - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

Organon drops after dividend cut - MSN

May 01, 2025
pulisher
May 01, 2025

Organon stock drops after dividend cut (OGN:NYSE) - Seeking Alpha

May 01, 2025
pulisher
May 01, 2025

Organon (OGN) Q1 Earnings Surpass Estimates - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Organon: Q1 Earnings Snapshot - San Antonio Express-News

May 01, 2025
pulisher
May 01, 2025

Organon in charts: Weak Q1 revenue across major business lines and regions (NYSE:OGN) - Seeking Alpha

May 01, 2025
pulisher
May 01, 2025

Organon stock falls as revenue misses estimates, guidance disappoints By Investing.com - Investing.com Nigeria

May 01, 2025
pulisher
May 01, 2025

Organon stock falls as revenue misses estimates, guidance disappoints - Investing.com

May 01, 2025
pulisher
May 01, 2025

Organon Reports Results for the First Quarter Ended March 31, 2025 - Business Wire

May 01, 2025
pulisher
May 01, 2025

Organon & Co. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

Organon Q1 2025 Earnings Preview - MSN

May 01, 2025
pulisher
Apr 30, 2025

Organon Q1 2025 Earnings Preview (OGN:NYSE) - Seeking Alpha

Apr 30, 2025
pulisher
Apr 30, 2025

Organon (OGN) Q1 Earnings: What To Expect - Yahoo Finance

Apr 30, 2025
pulisher
Apr 28, 2025

Organon (NYSE:OGN) Use Of Debt Could Be Considered Risky - simplywall.st

Apr 28, 2025
pulisher
Apr 28, 2025

Organon & Co (OGN) Shares Up 2.99% on Apr 28 - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Countdown to Organon (OGN) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance

Apr 28, 2025
pulisher
Apr 26, 2025

Organon (OGN) Ascends But Remains Behind Market: Some Facts to Note - MSN

Apr 26, 2025
pulisher
Apr 25, 2025

Organon & Co Receives a Shareholder Proposal from The New York City Carpenters Pension Fund - marketscreener.com

Apr 25, 2025

오가논 & Co (OGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general SNY
$55.09
price down icon 0.59%
drug_manufacturers_general PFE
$24.17
price up icon 1.15%
$103.31
price up icon 0.20%
$280.51
price down icon 1.01%
drug_manufacturers_general MRK
$82.83
price down icon 0.05%
drug_manufacturers_general NVS
$113.84
price down icon 0.28%
자본화:     |  볼륨(24시간):